Which of the following has the highest risk of causing invasive pulmonary aspergillosis?
Appeared in: INI-CET EXAM -2025
Explanation
Invasive Pulmonary Aspergillosis (IPA) is a life-threatening fungal infection caused by the Aspergillus species.
The body's primary defense mechanism against inhaled Aspergillus spores is the neutrophil, a type of white blood cell.
Febrile neutropenia is a condition characterized by a significantly low neutrophil count (neutropenia) and a fever, which is often a sign of infection.
This combination represents a critical failure of the body's main defense against Aspergillus, making it the single most important risk factor for the fungus to invade lung tissue and cause IPA.
Why Other Options Were Wrong
Option B: A CD4 count below 50 cells/μL indicates severe immunodeficiency (typically advanced HIV/AIDS), which is a defect in T-cell mediated immunity. While this increases the risk for many opportunistic infections, the risk for IPA is less pronounced compared to the risk associated with severe neutropenia.
Option C: Severe protein-energy undernutrition weakens the immune system globally. However, it is a non-specific risk factor and does not impair the specific line of defense (neutrophils) as severely as conditions like chemotherapy-induced neutropenia.
Option D: This is a crucial distractor. Bronchial asthma is a risk factor for a different condition called Allergic Bronchopulmonary Aspergillosis (ABPA), which is a hypersensitivity reaction to Aspergillus in the airways. It is not an invasive disease where the fungus grows into lung tissue.
Related Visual
Visual 1: Diagram - A flowchart comparing the pathophysiology of Invasive Pulmonary Aspergillosis (IPA) and Allergic Bronchopulmonary Aspergillosis (ABPA). IPA shows fungal hyphae invading lung tissue, while ABPA shows an allergic inflammatory response within the bronchial lumen.
Visual 2: Image - A chest CT scan showing the characteristic 'halo sign' or 'air crescent sign', which are highly suggestive of IPA in a neutropenic patient.
Clinical Relevance
Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Risk factors for opportunistic fungal infections, specifically Invasive Pulmonary Aspergillosis (IPA) as background academic context rather than a clinical decision trigger.
Nurses must maintain a high index of suspicion for IPA in immunocompromised patients, especially those in oncology and transplant units who present with fever and respiratory symptoms.
Strict neutropenic precautions, including protective isolation and HEPA filtration, are critical nursing interventions to prevent exposure to airborne fungal spores like Aspergillus in high-risk patients.
What if? If the patient had a history of cystic fibrosis or asthma and presented with worsening bronchospasm and brownish mucus plugs, the most likely diagnosis would be Allergic Bronchopulmonary Aspergillosis (ABPA), not IPA. The treatment would focus on corticosteroids and antifungals to reduce the allergic response, rather than aggressive systemic antifungal therapy for invasion.
How to Approach the Question
First, identify the key terms in the question: 'highest risk' and 'invasive pulmonary aspergillosis'. This tells you to compare the given conditions and find the strongest predisposing factor for this specific fungal infection.
Recall or determine the primary host defense against Aspergillus. The key immune cells are neutrophils.
Analyze each option based on its effect on the immune system, specifically on neutrophils.
Option A, 'Febrile neutropenia', directly points to a low count of the most critical defense cell (neutrophils) plus a sign of infection (fever). This is a perfect match for high risk.
Evaluate the other options. 'CD4 <50' relates to T-cells, not the primary defense. 'Undernutrition' is too general. 'Asthma' relates to an allergic form (ABPA), not the invasive form (IPA).
Conclude that the condition causing a severe and specific defect in the primary host defense (neutropenia) is the highest risk factor.